Cargando…

Phages and Nanotechnology: New Insights against Multidrug-Resistant Bacteria

Bacterial infections are a major threat to the human healthcare system worldwide, as antibiotics are becoming less effective due to the emergence of multidrug-resistant strains. Therefore, there is a need to explore nontraditional antimicrobial alternatives to support rapid interventions and combat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pardo-Freire, Marco, Domingo-Calap, Pilar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AAAS 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521656/ https://www.ncbi.nlm.nih.gov/pubmed/37849463 http://dx.doi.org/10.34133/bdr.0004

Ejemplares similares

Phage Therapy in Gastrointestinal Diseases
por: Gutiérrez, Beatriz, et al.
Publicado: (2020)

Phages for Biofilm Removal
por: Ferriol-González, Celia, et al.
Publicado: (2020)

Phage Therapy in Livestock and Companion Animals
por: Ferriol-González, Celia, et al.
Publicado: (2021)

Genetic and Chemical Engineering of Phages for Controlling Multidrug-Resistant Bacteria
por: Guo, Dingming, et al.
Publicado: (2021)

Different Nanotechnology Approaches for Ciprofloxacin Delivery Against Multidrug-Resistant Microbes
por: Yayehrad, Ashagrachew Tewabe, et al.
Publicado: (2022)

Phage Therapy in the Era of Multidrug Resistance in Bacteria: A Systematic Review
por: Aranaga, Carlos, et al.
Publicado: (2022)

Comparative Analysis of Novel Lytic Phages for Biological Control of Phytopathogenic Xanthomonas spp.
por: Domingo-Calap, M. L., et al.
Publicado: (2022)

Nanotechnological approaches for counteracting multidrug resistance in cancer
por: Martinelli, Chiara, et al.
Publicado: (2020)

Nanotechnology as a Promising Approach to Combat Multidrug Resistant Bacteria: A Comprehensive Review and Future Perspectives
por: Hetta, Helal F., et al.
Publicado: (2023)

Phage Therapy, a Salvage Treatment for Multidrug-Resistant Bacteria Causing Infective Endocarditis
por: Hetta, Helal F., et al.
Publicado: (2023)

Phages Needed against Resistant Bacteria
por: Moelling, Karin
Publicado: (2020)

Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology
por: Xue, Xue, et al.
Publicado: (2012)

Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer
por: Zhang, Meng, et al.
Publicado: (2017)

Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer
por: Yadav, Priya, et al.
Publicado: (2022)

Plazomicin against Multidrug-Resistant Bacteria: A Scoping Review
por: Alfieri, Aniello, et al.
Publicado: (2022)

Genetic determinants of host tropism in Klebsiella phages
por: Beamud, Beatriz, et al.
Publicado: (2023)

Isolation and Characterization of Two Klebsiella pneumoniae Phages Encoding Divergent Depolymerases
por: Domingo-Calap, Pilar, et al.
Publicado: (2020)

An Update on Eight “New” Antibiotics against Multidrug-Resistant Gram-Negative Bacteria
por: Yusuf, Erlangga, et al.
Publicado: (2021)

Biogenic Nanosilver against Multidrug-Resistant Bacteria (MDRB)
por: Barros, Caio H. N., et al.
Publicado: (2018)

Learning From Mistakes: The Role of Phages in Pandemics
por: Alsaadi, Ahlam, et al.
Publicado: (2021)

Evolutionary Dynamics between Phages and Bacteria as a Possible Approach for Designing Effective Phage Therapies against Antibiotic-Resistant Bacteria
por: Hasan, Mahadi, et al.
Publicado: (2022)

Nanotechnology-Based Strategies to Combat Multidrug-Resistant Candida auris Infections
por: Hetta, Helal F., et al.
Publicado: (2023)

Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review
por: Mir, Suhail Ahmad, et al.
Publicado: (2022)

Isolation of Four Lytic Phages Infecting Klebsiella pneumoniae K22 Clinical Isolates from Spain
por: Domingo-Calap, Pilar, et al.
Publicado: (2020)

Phage Display-Based Nanotechnology Applications in Cancer Immunotherapy
por: Goracci, Martina, et al.
Publicado: (2020)

Bacteriophage: Time to Re-Evaluate the Potential of Phage Therapy as a Promising Agent to Control Multidrug-Resistant Bacteria
por: Sabouri Ghannad, Masoud, et al.
Publicado: (2012)

Mechanisms of viral mutation
por: Sanjuán, Rafael, et al.
Publicado: (2016)

Phage engineering and phage‐assisted CRISPR‐Cas delivery to combat multidrug‐resistant pathogens
por: Khambhati, Khushal, et al.
Publicado: (2022)

Essential Topics for the Regulatory Consideration of Phages as Clinically Valuable Therapeutic Agents: A Perspective from Spain
por: Vázquez, Roberto, et al.
Publicado: (2022)

Efficacy and potential of phage therapy against multidrug resistant Shigella spp.
por: Tang, Swee-Seong, et al.
Publicado: (2019)

Phage Revolution Against Multidrug-Resistant Clinical Pathogens in Southeast Asia
por: Carascal, Mark B., et al.
Publicado: (2022)

Potentiation and Mechanism of Berberine as an Antibiotic Adjuvant Against Multidrug-Resistant Bacteria
por: Zhou, Hongjuan, et al.
Publicado: (2023)

Bacteriophages: Protagonists of a Post-Antibiotic Era
por: Domingo-Calap, Pilar, et al.
Publicado: (2018)

Recent Progress of Novel Nanotechnology Challenging the Multidrug Resistance of Cancer
por: Zhang, Chengyuan, et al.
Publicado: (2022)

Current Treatment Strategies Against Multidrug-Resistant Bacteria: A Review
por: Parmanik, Ankita, et al.
Publicado: (2022)

Phage-Derived Depolymerase as an Antibiotic Adjuvant Against Multidrug-Resistant Acinetobacter baumannii
por: Chen, Xi, et al.
Publicado: (2022)

Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria
por: Liu, Yuan, et al.
Publicado: (2021)

New insights into intestinal phages
por: Sausset, R., et al.
Publicado: (2020)

Cefiderocol, a new antibiotic against multidrug-resistant Gram-negative bacteria
por: Silva, José Tiago, et al.
Publicado: (2021)

Recent advances in nanoantibiotics against multidrug-resistant bacteria
por: Li, Mulan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rspm1rfh5kq7fgn89gils918dt